Abstract
In order to investigate the biological processes underlying and resulting from the The formation of platelets from MKs and MK senescence in vitro has been shown to be associated with apoptosis (6). Zauli et al. previously generated MKs in serum-free (SF) suspension cultures of normal CD34+ cells in the presence TPO (7) . The peak generation of MKs occurred after 12 to 15 days of culture. A progressive increase in MK undergoing apoptosis was observed after 15 days with more than 50% of the cells undergoing apoptosis after 18 days of culture (8, 9) . Changes in the levels of bcl-xL, an antiapoptotic protein (9) , in MKs have been correlated with MK ultrastructure and platelet levels. High levels of expression of bcl-xL have been shown to impact the ability of MKs to fragment into platelets (10) . Apoptosis has been previously reported to be dysregulated in the MPDs, including PV and essential thrombocythemia (ET) (11, 12) . Bcl-xL has been shown to be responsible for giving rise to erythropoietin-independent erythroid colony formation in PV (13) . We hypothesized that a greater ability of IMF CD34+ cells to generate MK as well as delayed MK apoptosis might contribute to the MK hyperplasia in
IMF.
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From Recently, a mutation in the JH2 domain of the JAK2 tyrosine kinase (JAK2V617F) has been identified in the Philadelphia chromosome (Ph)-negative MPDs and has been shown to be associated with hypersensitivity of hematopoietic progenitor cells to cytokines (14) . The JAK2V617F mutation is present in about 50% of patients with IMF but its role in the pathogenesis of this disease remains uncertain (15) . In addition, about 10 % of IMF patients negative for JAK2V617F have been found to have an activating mutation in the c-MPL (MPLW515L), which also confers cytokineindependent proliferation, and results in constitutive phosphorylation of the JAK2, STAT 3, STAT 5, AKT and ERK (16) . We therefore determined whether the JAK2V617F mutation in IMF CD34+ cells affected the behavior of IMF MKs.
In IMF, MKs have been suggested to be responsible for the BM fibrosis due to the local release of fibrogenic growth factors (17, 18) . TGF-β is an important growth factor, which promotes the extracellular matrix deposition, angiogenesis (19) and fibrosis (20, 21) . Other factors including platelet-derived growth factor (PDGF), basic fibroblast growth factor-2 (bFGF) and vascular endothelial growth factor (VEGF) have also been implicated in the generation of the BM fibrosis or the increased BM microvessel density characteristic of this disorder (22, 23, 24) . In addition, we have previously reported that IMF patients have significantly higher plasma levels of proteases including neutrophil elastase (NE), and matrix metalloproteinase-9 (MMP-9) creating a proteolytic marrow microenvironment likely responsible for the constitutive mobilization of CD34+ cells into the peripheral blood in these patients (25) . We therefore examined if these cytokines or proteases were produced preferentially by IMF MKs.
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Materials and methods

Patient specimens and CD34+ cells isolation
Peripheral blood (PB) was collected from 10 normal volunteers mobilized with granulocyte colony stimulating factor (G-CSF) (MPB), 12 patients who fulfilled the Italian diagnostic criteria for the diagnosis of IMF (26) and 4 patients with PV diagnosed according to the Polycythemia Vera Study Group criteria (3). The PB from the PV patients was collected as part of a therapeutic phlebotomy. All patients had signed an informed consent approved by the Institutional Review Board of the University of Illinois at Chicago.
Mononuclear cells (MNC) were isolated by density gradient centrifugation using Ficoll-Paque (GE Healthcare Bio-Science AB, Uppsala, Sweden). CD34+ cells were then selected using a CD34+ Isolation Kit (Miltenyi Biotec, Auburn, CA). The purity of CD34+ cells was verified using CD34-PE flow cytometrically. A CD34+ cell population with purity of at least 85% was used for all studies.
Clinical characteristics IMF patients were between 44 and 66 years of age (mean 53 years). 50% of these patients were JAK2V617F positive and all patients were negative for the MPLW515L mutation. All IMF patients had moderate to massive splenomegaly, at least 1+ bone marrow fibrosis, peripheral blast count less than 3% and a Lille score of 0 to 2. Half the patients had anemia and 20% had marker chromosomal abnormalities. Each of the PV patients were JAK2V617F positive, 2 were heterozygous and 2 homozygous for the mutation. The average age of the PV patients was 50 (ranging between 39 and 60 years)
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JAK2V617F and MPLW515L mutational analysis
The presence of JAK2V617F and MPLW515L mutation was determined in the PB MNC of patients with IMF as previously described (27, 28) . Briefly, genomic DNA (gDNA) was extracted from MNC using Easy-DNA TM Kit (Invitrogen, Carlsbad, CA) and was amplified using primers 5'-GATCTCCATATTCCAGGCTTACACA-3' and 5'-TATTGTTTGGGCATTGTAACCTTCT-3', which cover JAK2V617F mutation site; as well as using primers 5'-TgggCCgAAgTCTgACCCTTT-3' and 5'-ACAgAgCgAACCAAgAATgCCTgT-3', which cover the MPLW515L mutational site.
PCR was performed with DNA polymerase iTaq TM (BiO-Rad,). The PCR products were gel purified and sequenced directly using the ABI 3730xl DNA analyzer at the DNA Sequencing Facility of the University of Illinois at Chicago. Among the 12 IMF patients used in this study, 6 patients were JAK2V617F positive and none of them were MPLW515L positive.
Suspension cultures
CD34+ cells were cultured in serum free media (StemSpan® SFEM, Stem Cell
Technologies, Vancouver, BC) at a concentration of 50,000 cells/ml in the presence or absence of cytokines (7) . Every 4 days, half of the media was exchanged with fresh media containing cytokines. Individual cultures of CD34+ cells were performed with varying doses of TPO (0, 5, 50, 100, 200 ng/ml) and a fixed amount of SCF (100ng/ml).
On day 15, cells from the cultures performed with 100ng/ml TPO and SCF were washed 
Morphologic analysis
Primary cells after 8, 11 and 15 days of cultures and CD61+ selected cells after 3, 5 and 7 days of secondary cultures were spun using a Cytospin 3 (Thermo Shandon, Astmoor, England) onto glass slides. Cells were stained with May-Grunwald-Giemsa and MK morphology evaluated using a light microscope (Olympus BX40F-3). Cells were washed, re-suspended in MACS buffer and analyzed flow cytometrically.
Flow cytometric analysis
CD41/Propidium iodide (PI) (
ELISA assays
Frozen samples of CM were thawed overnight at 4˚C and analyzed using commercially available enzyme-linked immunosorbent assays (ELISA) kits for levels of various growth factors and proteases including TGF-β1, bFGF-2, PDGF, VEGF, MMP-9 and MMP-2, (R&D Systems, Minneapolis, MN) and NE (Cell Sciences, Canton, MA) according to the manufacturer's recommendations. Briefly, after appropriate dilution and standard curve preparation, plates coated with various antibodies were incubated for 2h at room temperature in the presence of CM from different samples. After incubation, the wells were washed with a Wash Buffer using an ELx50 washing machine (Bio-Tek, Winooski, VT) and a corresponding conjugate added to each sample followed by a re-incubation.
Samples were again washed and the Substrate Solution added to each well. After a brief incubation, a Stop Solution provided with each kit was used to terminate the reaction and 
Statistical analysis
The results were expressed as the mean ± the standard deviation (SD) or standard error of the mean (SEM) of data obtained from varying numbers of individual experiments.
Differences between the experimental groups were assessed using unpaired two-sided Student's t test. Statistical significance was defined as P value of less than 0.05. In the presence of maximal cytokine concentrations (100ng/ml SCF and 100ng/ml TPO) the total number of cells generated after 15 days of culture by IMF CD34+ cells The levels of active MMP-9 were also quantitated in the CM prepared with normal and IMF cells. In primary cultures after 15 days, the IMF CM contained 29.8 ± 10 ng/ml as compared with the normal CM, which contained 2.7 ± 0.5 ng/ml (P < .05).
Results
IMF
Secondary cultures of IMF CD61+ cells after 3 days contained 7.6 ± 1.9 ng/ml while normal CD61+ CM prepared with similar number of MKs contained 3.76 ± 0.21 ng/ml MMP-9 (P < .05). By contrast, PV cultures contained intermediate levels of MMP-9
( Figure 6C, D) . These data demonstrate that the intrinsic behavior of IMF MKs is characterized by excessive production of TGF-β and active MMP-9.
The concentration of VEGF was also found to be significantly increased in the CM from IMF samples as compared with normal controls. Four times greater concentrations of VEGF were found in the IMF CM after 15 days of CD34+ cell culture (2552.2 ± 672.5 pg/ml) as compared with normal samples (672.5 ± 220.4 pg/ml) (P < .01) ( Figure 6B ). Equal numbers of IMF and normal CD61+ cells selected after 15 days produced similar amounts of VEGF after 3 additional days of secondary cultures (120.7 ± 62.2 pg/ml vs. 137 ± 34.1 pg/ml) ( Figure 6C ). Our experiments indicate that IMF cultures generate greater amounts of VEGF, but, unlike TGF-beta or MMP-9, IMF MKs do not appear to possess a greater ability to produce VEGF than normal MKs. The higher levels of VEGF found in CM prepared with IM CD34+ cells after 15 days of culture can, For personal use only. on September 14, 2017. by guest www.bloodjournal.org From likely, be attributed to the greater absolute number of MKs present in such cultures. We did not identify a significant difference in the levels of TGF-β, active MMP-9 and VEGF between the CM prepared from primary and secondary cultures of patients with JAK2V617F positive or negative IMF (data not shown).
In addition, the ability of IMF MKs to produce other growth factors and proteases was examined. PDGF, bFGF, MMP-2 and NE were not detected in CM generated from both the primary and the secondary cultures of either normal or IMF cells performed under the conditions described above.
Correlation of MK abnormalities with clinical phenotype
No significant correlations were found between the number of total cells or CD41+ cells generated in vitro from IMF CD34+ cells, the presence or absence of JAK2V617F mutation, the levels of bcl-xL over-expression and the clinical features of the IMF patients (the degree of BM fibrosis, the spleen size, the percentage of blast count in the peripheral blood, Lille score). Both JAK2V617F positive and negative IMF patients had similar degrees of splenomegaly, degree of BM fibrosis, and Lille scores. The ability to generate total cells and CD41+ cells from PV CD34+ cells tended to be greater in two samples isolated from patients homozygous for JAK2V617F.
Discussion
IMF is a Ph-chromosome negative MPD characterized by MK hyperplasia, BM fibrosis, increase BM microvessel density (30) and constitutive mobilization of CD34+ cells in the circulation (31) . BM hyperplasia of morphologically abnormal MKs is a hallmark of IMF. We hypothesize that MK proliferation is at the center of the pathogenesis of this disease, and that MKs play a crucial role in the disease progression Previously, several investigators have reported the results of studies using suspension cell cultures, which favored the differentiation of normal CD34+ cells into MK in vitro using media supplemented with SCF and TPO (7, 8) . Progressive MK apoptosis was observed after 15 days of culture (7, 8) . MK apoptosis was correlated with the decreased expression of an anti-apoptotic protein bcl-xL but not with changes in bcl-2 expression (33). Bcl-xL is an important regulatory protein associated with normal MK development. Levels of this protein have been shown to decrease progressively according to the stages of normal MK differentiation (8) . In addition, Kaluzhny and colleagues have shown that over-expression of MK bcl-xL resulted in an increased MK numbers and decreased apoptosis and the ability of these cells to generate pro-platelets (10).
We investigated the origins of MK hyperplasia in IMF as well as the production of growth factors and proteases by MKs using a modification of the "two step" MK culture system described by Majka and colleagues (34) . In this system utilized, MK formation by normal CD34+ cells was dependant on the addition of exogenous TPO.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Previously, MK colony formation in semisolid media was however, reported to occur in the absence of TPO (35) . We were able to confirm this characteristic of IMF MKs using suspension cell cultures. We have found that PB IMF CD34+ cells generated more than 16- TGF-β can also act as a regulator of cellular proliferation, migration, survival and differentiation. Genetic studies in humans have also revealed the role of TGF-β as well as its signaling components in angiogenesis (38) . TGF-β has a dual role in cancer progression. Although TGF-β is a potent tumor suppressor, it has been reported to TGF-beta has been shown to cause BM fibrosis and osteosclerosis in mouse models (40) .
Our work showed that IMF MKs are a major source of TGF-β, and that abnormal MKs in IMF, due to their increased ability to produce TGF-β, likely play an important role in the generation of the BM fibrosis in these patients.
Matrix metalloproteinases have been implicated in promoting tumor angiogenesis and metastases (41) and have been shown to play an important role in angiogenesis, collagen degradation and mobilization of HSC/HPC. MMPs are secreted as latent proenzyme forms, which require activation in order for the proteolysis to occur (42) . We have previously shown that active MMP-9 is increased in the plasma of patients with IMF (25) . We now demonstrate that IMF CMs from both primary and secondary MK cultures contain significantly greater amounts of MMP-9. The increased production of active MMP-9 by IMF MKs, might also contribute to the release of progenitor cells into the circulation of patients with IMF by degrading SDF-1 or cleaving its receptor CXCR-4 (33).
VEGF is a potent pro-angiogenic growth factor responsible for endothelial cell proliferation and differentiation, shown by Mohle et al. to be expressed by normal MKs and myeloid progenitors (42) . Serum VEGF levels have been reported to be 10 times higher in the PB of IMF patients as compared with normal subjects (24) . Although IMF and normal MKs appear to be equivalent in their ability to produce VEGF, our results indicate an increased production of VEGF in the IMF CD34+ cell cultures as compared with normal controls after 15 days of culture, a likely consequence of increased number Figure 2B represents the absolute number of CD41+ cells generated after 15 days in the same cultures. The numbers of CD41+ cells generated by IMF CD34+ cells was statistically greater than the numbers generated by normal CD34+ cells (n = 4) or PV CD34+ cells (P < .05). No significant difference in the absolute numbers of cells ( Figure 2C Figure 2D ) generated by the CD34+ cells obtained from patients with JAK2V617F positive and negative IMF was found (P > .05). in the CM from normal, IMF and PV cultures in primary and secondary cultures as mentioned above. Significantly greater levels of active MMP-9 were found in the IMF CM both after 15 days of primary cultures and 3 days of secondary cultures as compared with normal samples (P < .05). VEGF levels were also measured in the CM from these cultures ( Figures 6E and 6F) . In contrast to TGF-β or active MMP-9, the levels of VEGF were not found to be elevated in the IMF CM after 3 days of secondary cultures ( Figure   6F ), however, greater levels of VEGF were found in the IMF CM from primary cultures ( Figure 6E ) (P < .05), probably related to the greater numbers of MKs found in these cultures. 
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